ALLMedicine™ Meningioma Center
Research & Reviews 2,394 results
https://doi.org/10.1136/bcr-2021-247792
BMJ Case Reports; Valappil A, Sundar S S et. al.
May 18th, 2022 - We present a unique case of biopsy-proven necrotising sarcoidosis involving the central nervous system in a man in his 40s. The patient presented with a 2-week history of right-sided headache and diplopia. He had right trochlear and abducens nerve...
https://clinicaltrials.gov/ct2/show/NCT04082520
May 17th, 2022 - PRIMARY OBJECTIVES: I. To estimate the efficacy of lutetium Lu 177 dotatate (LUTATHERA) treatment in patients with recurrent grade 1 meningioma as measured by 6-month progression-free survival (PFS) rate. II. To estimate the efficacy of LUTATHERA ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107722
Acta Neuropathologica Communications; Teranishi Y, Okano A et. al.
May 16th, 2022 - NF2 alteration is the most commonly-found genetic abnormality in meningiomas and is known to initiate events for aggressive-type meningiomas. Whereas the prognosis of meningiomas differs depending on their epigenomic/transcriptomic profile, the ef...
https://doi.org/10.1097/IOP.0000000000002200
Ophthalmic Plastic and Reconstructive Surgery; Tynan D, Ng J et. al.
May 14th, 2022 - The authors describe a rare case of primary extradural ectopic meningioma of the orbit in a 13-year-old female managed with surgical excision, adding to the very limited literature of this diagnosis in children. This is the second case to show a r...
https://doi.org/10.1227/neu.0000000000002026
Neurosurgery Slavik H, Balik V et. al.
May 14th, 2022 - Meningioma is the most common primary central nervous system neoplasm, accounting for about a third of all brain tumors. Because their growth rates and prognosis cannot be accurately estimated, biomarkers that enable prediction of their biological...
Guidelines 1 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566438
Neurosurgery Marchetti M, Sahgal A et. al.
May 29th, 2020 - Stereotactic radiosurgery (SRS) for benign intracranial meningiomas is an established treatment. To summarize the literature and provide evidence-based practice guidelines on behalf of the International Stereotactic Radiosurgery Society (ISRS). Ar...
Clinicaltrials.gov 36 results
https://clinicaltrials.gov/ct2/show/NCT04082520
May 17th, 2022 - PRIMARY OBJECTIVES: I. To estimate the efficacy of lutetium Lu 177 dotatate (LUTATHERA) treatment in patients with recurrent grade 1 meningioma as measured by 6-month progression-free survival (PFS) rate. II. To estimate the efficacy of LUTATHERA ...
https://clinicaltrials.gov/ct2/show/NCT02282917
May 11th, 2022 - This is a multi-center, proof of concept phase 0 study to assess the suppression of p-AKT in VS and meningiomas by AR-42 in adult patients undergoing NF2-tumor resection. AR-42 will be administered three times per week beginning 3 weeks prior to s...
https://clinicaltrials.gov/ct2/show/NCT02847559
Apr 22nd, 2022 - PRIMARY OBJECTIVES: I. To determine progression free survival (PFS) for 6 months (PFS-6) in patients with recurrent or progressive meningioma. SECONDARY OBJECTIVES: I. To determine overall survival (OS). II. To determine tumor response rate (TRR)....
https://clinicaltrials.gov/ct2/show/NCT04305470
Apr 20th, 2022 - This Phase 3 open-label single-arm study is designed to investigate the safety, diagnostic performance, and clinical usefulness of the imaging agent Gleolan™ (Aminolevulinic Acid Hydrochloride, ALA HCl, ALA, 5-ALA), an orally administered imaging ...
https://clinicaltrials.gov/ct2/show/NCT02523014
Apr 19th, 2022 - PRIMARY OBJECTIVES: I. To determine the activity of a SMO inhibitor in patients with meningiomas harboring SMO and PTCH1 mutations as measured by 6-month progression free survival (PFS) and response rate. II. To determine the activity of a FAK inh...
News 50 results
https://www.medscape.com/viewarticle/968594
Feb 15th, 2022 - New research shows that men in their 20s and 30s have worse survival from many different types of brain tumors than women of the same age. And, researchers say, it’s not exactly clear why. Differences in treatment may mediate some of the associati...
https://www.medscape.com/viewarticle/959973
Oct 6th, 2021 - By 2030, it is projected that most Americans will be overweight, and of those, nearly 50% of adults will be obese. Although the majority of Americans are aware that obesity can have adverse health consequences, survey findings show that few are aw...
https://www.medscape.com/viewarticle/945218
Feb 3rd, 2021 - New details confirm an increased risk of developing intracranial meningiomas after prolonged use of the hormonal product cyproterone acetate. Cyproterone acetate is a synthetic progestogen and potent anti-androgen that has been used in the treatme...
https://www.onclive.com/view/meningioma-may-be-tied-to-dental-x-rays
Dec 5th, 2020 - Elizabeth B. Claus, MD New data suggest that dental x-rays obtained frequently at a young age may boost the risk of intracranial meningioma. Although dental x-rays are an important tool in well selected patients, efforts to moderate exposure to ...
https://www.onclive.com/view/direct-targeting-of-ret-aberrations-moves-closer-to-the-clinic
Dec 5th, 2020 - Alexander Drilon, MD Research on the proto-oncogene RET has accelerated exponentially since 1985, when Masahide Takahashi, MD, PhD, and colleagues first reported a fusion rearrangement in lymphoma DNA.1 Early progress was slow. Other investigator...